Journal of Hepatology
Volume 49, Issue 2 , Pages 163-169, August 2008

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients☆

  • Eric Lawitz

      Affiliations

    • Alamo Medical Research, 621 Camden Suite 202, San Antonio, TX 78215, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 210 253 3426; fax: +1 210 227 6951.
    • Contributed equally to the study.
    • ,
  • Maribel Rodriguez-Torres

      Affiliations

    • Fundacion de Investigacion de Diego San Juan, Puerto Rico, NC, USA
    • Contributed equally to the study.
    • ,
  • Andrew J. Muir

      Affiliations

    • Duke Clinical Research Institute, Division of Gastroenterology, Duke University, Durham, NC, USA
    • ,
  • Tara L. Kieffer

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
    • ,
  • Lindsay McNair

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
    • ,
  • Ariya Khunvichai

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
    • ,
  • John G. McHutchison

      Affiliations

    • Duke Clinical Research Institute, Division of Gastroenterology, Duke University, Durham, NC, USA

Received 25 August 2007; received in revised form 23 February 2008; accepted 13 March 2008. published online 29 April 2008.

Associate Editor: M.P. Manns

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was supported by Vertex Pharmaceuticals Incorporated. The authors who have taken part in the research of this paper declared that they have a relationship with the manufacturers of the drugs involved either in the past or present and that they received funding from the manufacturers to carry out their research. Drs. Kieffer, McNair and Khunvichai are employees of Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA.

PII: S0168-8278(08)00281-X

doi:10.1016/j.jhep.2008.03.027

Journal of Hepatology
Volume 49, Issue 2 , Pages 163-169, August 2008

Article Tools

* Image Usage & Resolution